Reported about 1 month ago
Billionaires Ken Griffin and Israel Englander recently purchased shares in Pfizer, a pharmaceutical company facing significant stock performance challenges. Despite a troubling history marked by the decline in demand for its COVID-19 treatments, Pfizer's recent $43 billion acquisition of an oncology business and potential ventures in weight loss medications may present growth opportunities. However, analysts caution that while these investments could be strategic, the future success of Pfizer remains uncertain.
Source: YAHOO